ESSA Pharma Ownership | Who Owns ESSA Pharma?
ESSA Pharma Ownership Summary
ESSA Pharma is owned by 9.96% institutional investors, 6.02% insiders, and 84.02% retail investors. Bvf inc/il is the largest institutional shareholder, holding 19.76% of EPIX shares. BB Biotech AG Ord is the top mutual fund, with 17.76% of its assets in ESSA Pharma shares.
EPIX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | ESSA Pharma | 9.96% | 6.02% | 84.02% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Bvf inc/il | 8.75M | 19.76% | $15.66M |
Tang capital management | 4.30M | 9.71% | $7.70M |
Bml capital management | 4.22M | 9.53% | $7.56M |
Morgan stanley | 4.18M | 9.44% | $21.98M |
Rtw investments, lp | 2.30M | 5.20% | $12.09M |
Soleus capital management | 2.26M | 5.11% | $4.05M |
Opaleye management | 2.21M | 4.99% | $3.96M |
Pfizer | 1.68M | 3.78% | $3.00M |
Altium capital management lp | 1.43M | 3.23% | $2.56M |
Aldebaran capital | 397.52K | 0.90% | $711.57K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Bml capital management | 4.22M | 4.69% | $7.56M |
Altium capital management lp | 1.43M | 0.72% | $2.56M |
Opaleye management | 2.21M | 0.69% | $3.96M |
Aldebaran capital | 397.52K | 0.68% | $711.57K |
Bvf inc/il | 8.75M | 0.53% | $15.66M |
Tang capital management | 4.30M | 0.51% | $7.70M |
Vazirani asset management | 50.00K | 0.28% | $89.50K |
Soleus capital management | 2.26M | 0.25% | $4.05M |
Rtw investments, lp | 2.30M | 0.19% | $12.09M |
Pfizer | 1.68M | 0.12% | $3.00M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Tang capital management | 4.30M | 0.51% | 4.30M |
Bml capital management | 4.22M | 4.69% | 4.22M |
Opaleye management | 2.21M | 0.69% | 2.21M |
Pfizer | 1.68M | 0.12% | 1.68M |
Altium capital management lp | 1.43M | 0.72% | 1.43M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Bellevue group | - | - | -7.88M |
Pfm health sciences, lp | - | - | -2.74M |
Soleus capital management | 2.26M | 0.25% | -2.03M |
Adage capital partners gp | - | - | -1.47M |
Janus henderson group | - | - | -1.01M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Tang capital management | 4.30M | 0.51% | 4.30M | $7.70M |
Bml capital management | 4.22M | 4.69% | 4.22M | $7.56M |
Opaleye management | 2.21M | 0.69% | 2.21M | $3.96M |
Pfizer | 1.68M | 0.12% | 1.68M | $3.00M |
Altium capital management lp | 1.43M | 0.72% | 1.43M | $2.56M |
Sold Out
Holder | Change |
---|---|
Toronto dominion bank | -48.00 |
Entrypoint capital | -4.42K |
Simplex trading | -5.16K |
Millennium management | -14.05K |
Tucker asset management | -16.10K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 10 | -71.43% | 4,411,627 | -87.43% | 9 | 0.16% | 7 | -53.33% | 1 | -87.50% |
Sep 30, 2024 | 35 | 2.94% | 35,103,052 | -0.30% | 79 | 1.25% | 15 | 87.50% | 8 | -27.27% |
Jun 30, 2024 | 34 | -8.11% | 35,208,390 | 0.49% | 79 | 1.26% | 8 | -33.33% | 11 | 10.00% |
Mar 31, 2024 | 37 | 5.71% | 35,037,057 | 0.76% | 79 | 1.28% | 12 | -20.00% | 10 | 66.67% |
Dec 31, 2023 | 35 | -10.26% | 34,772,388 | 3.89% | 78 | 1.37% | 15 | 25.00% | 6 | -40.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
BB Biotech AG Ord | 7.88M | 17.76% | - |
Rhenman Healthcare Equity L/S RC2 SEK | 804.65K | 1.81% | - |
SQUAD Aguja Opportunities I | 500.00K | 1.13% | - |
MEDICAL BioHealth EUR Acc | 214.80K | 0.48% | - |
RIM Global Bioscience EUR | 54.50K | 0.12% | - |
Avantis US Small Cap Equity ETF | 46.37K | 0.10% | - |
Kennedy Micro Cap Opportunities | 40.85K | 0.09% | 7.46K |
Fidelity Nasdaq Composite Index | 26.86K | 0.06% | - |
Bellevue (Lux) Bellevue Glbl Mac I EUR | 10.00K | 0.02% | - |
North Square Kennedy MicroCap I | 5.85K | 0.01% | 5.22K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 01, 2024 | BIOTECH GROWTH N V | - | Sell | $2.84M |
Nov 01, 2024 | BIOTECH GROWTH N V | - | Sell | $3.06M |
Nov 01, 2024 | BIOTECH GROWTH N V | - | Sell | $3.05M |
Nov 01, 2024 | BIOTECH GROWTH N V | - | Sell | $3.06M |
Sep 09, 2024 | Virsik Peter | Chief Operating Officer | Sell | $4.16K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q3 | - | 2 |
2024 Q2 | - | 2 |
2024 Q1 | - | 6 |
2023 Q4 | 4 | - |
2023 Q2 | - | - |
EPIX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools